Hemoglobin, hematocrit, and changes in cerebral blood flow: The Second Manifestations of ARTerial disease-Magnetic Resonance study

Neurobiology of Aging

Volumn 36, Issue 3, 2015, Pages 1417-1423

  van der Veen, Pieternella H ^a   Muller, Majon ^a,b   Vincken, Koen L ^c   Westerink, Jan ^a   Mali, Willem P T M ^a   van der Graaf, Yolanda ^a   Geerlings, Mirjam I ^a   Algra, A ^a   Doevendans P A , ^d   van der Graaf Y , ^e   Grobbee, D E ^e   Rutten, G E H M ^e   Kappelle, L J ^f   Mali, W P T M ^d   Moll, F L ^d   Visseren, F L J ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Department of Cardiology ^*  (Netherlands)

^e Julius Center for Health Sciences and Primary Care   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atherosclerosis; Brain imaging; Cerebral blood flow; Hemorheology; Magnetic resonance imaging

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIURETIC AGENT; HEMOGLOBIN; BIOLOGICAL MARKER; OXYGEN;

ADULT; ARTERY DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN TISSUE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMATOCRIT; HEMODYNAMICS; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE VALUE; VASCULAR DISEASE; AGED; ATHEROSCLEROSIS; BLOOD; BLOOD VISCOSITY; BRAIN CIRCULATION; MIDDLE AGED; PATHOPHYSIOLOGY; STATISTICAL MODEL;

AGED; ATHEROSCLEROSIS; BIOMARKERS; BLOOD VISCOSITY; CEREBROVASCULAR CIRCULATION; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMATOCRIT; HEMOGLOBINS; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; OXYGEN; PROSPECTIVE STUDIES;

EID: 84923544645     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.12.019     Document Type: Article

References (32)

1. Alosco M.L., Gunstad J., Jerskey B.A., Xu X., Clark U.S., Hassenstab J., Cote D.M., Walsh E.G., Labbe D.R., Hoge R., Cohen R.A., Sweet L.H. The adverse effects of reduced cerebral perfusion on cognition and brain structure in older adults with cardiovascular disease. Brain Behav. 2013, 3:626-636.
2. Anbeek P., Vincken K.L., van Bochove G.S., van Osch M.J., van der Grond J. Probabilistic segmentation of brain tissue in MR imaging. Neuroimage 2005, 27:795-804.
3. Appelman A.P., van der Graaf Y., Vincken K.L., Tiehuis A.M., Witkamp T.D., Mali W.P., Geerlings M.I. Total cerebral blood flow, white matter lesions and brain atrophy: the SMART-MR study. J.Cereb. Blood Flow Metab. 2008, 28:633-639.
4. Bakker C.J., Kouwenhoven M., Hartkamp M.J., Hoogeveen R.M., Mali W.P. Accuracy and precision of time-averaged flow as measured by nontriggered 2D phase-contrast MR angiography, a phantom evaluation. Magn. Reson. Imaging 1995, 13:959-965.
5. Brown D.W., Giles W.H., Croft J.B. Hematocrit and the risk of coronary heart disease mortality. Am. Heart J. 2001, 142:657-663.
6. Brown M.M., Marshall J. Regulation of cerebral blood flow in response to changes in blood viscosity. Lancet 1985, 1:604-609.
7. Cole D.J., Drummond J.C., Patel P.M., Marcantonio S. Effects of viscosity and oxygen content on cerebral blood flow in ischemic and normal rat brain. J.Neurol. Sci. 1994, 124:15-20.
8. Dijk J.M., Wangge G., van der Graaf Y., Bots M.L., Grobbee D.E., Algra A. Hemoglobin and atherosclerosis in patients with manifest arterial disease. The SMART-study. Atherosclerosis 2006, 188:444-449.
9. Donders A.R., van der Heijden G.J., Stijnen T., Moons K.G. Review: a gentle introduction to imputation of missing values. J.Clin. Epidemiol. 2006, 59:1087-1091.
10. Floyd T.F., McGarvey M., Ochroch E.A., Cheung A.T., Augoustides J.A., Bavaria J.E., Acker M.A., Pochettino A., Detre J.A. Perioperative changes in cerebral blood flow after cardiac surgery: influence of anemia and aging. Ann. Thorac. Surg. 2003, 76:2037-2042.
11. Gagnon D.R., Zhang T.J., Brand F.N., Kannel W.B. Hematocrit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up. Am. Heart J. 1994, 127:674-682.
12. Geerlings M.I., Appelman A.P., Vincken K.L., Algra A., Witkamp T.D., Mali W.P., van der Graaf Y. Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART-MR study. Atherosclerosis 2010, 210:130-136.
13. Gottesman R.F., Sojkova J., Beason-Held L.L., An Y., Longo D.L., Ferrucci L., Resnick S.M. Patterns of regional cerebral blood flow associated with low hemoglobin in the Baltimore Longitudinal Study of Aging. J.Gerontol. A Biol. Sci. Med. Sci. 2012, 67:963-969.
14. Grimaldi E., Scopacasa F. Evaluation of the Abbott CELL-DYN 4000 hematology analyzer. Am. J. Clin. Pathol. 2000, 113:497-505.
15. Holsworth R., Cho Y., Weidman J.J., Sloop G., St Cyr J. Cardiovascular benefits of phlebotomy: relationship to changes in hemorheological variables. Perfusion 2014, 29:102-116.
16. Ibaraki M., Shinohara Y., Nakamura K., Miura S., Kinoshita F., Kinoshita T. Interindividual variations of cerebral blood flow, oxygen delivery, andmetabolism in relation to hemoglobin concentration measured by positronemission tomography in humans. J.Cereb. Blood Flow Metab. 2010, 30:1296-1305.
17. Jae S.Y., Kurl S., Laukkanen J.A., Heffernan K.S., Choo J., Choi Y.H., Park J.B. Higher blood hematocrit predicts hypertension in men. J.Hypertens. 2014, 32:245-250.
18. Kensey K.R. The mechanistic relationships between hemorheological characteristics and cardiovascular disease. Curr. Med. Res. Opin. 2003, 19:587-596.
19. Kirkness C.J. Cerebral blood flow monitoring in clinical practice. AACN Clin. Issues 2005, 16:476-487.
20. Landolfi R., Marchioli R., Kutti J., Gisslinger H., Tognoni G., Patrono C., Barbui T. Efficacy and safety of low-dose aspirin in polycythemia vera. N.Engl. J. Med. 2004, 350:114-124.
21. Lee A.J., Mowbray P.I., Lowe G.D., Rumley A., Fowkes F.G., Allan P.L. Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery Study. Circulation 1998, 97:1467-1473.
22. Marstrand J.R., Garde E., Rostrup E., Ring P., Rosenbaum S., Mortensen E.L., Larsson H.B. Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke 2002, 33:972-976.
23. Metry G., Wikstrom B., Valind S., Sandhagen B., Linde T., Beshara S., Langstrom B., Danielson B.G. Effect of normalization of hematocrit on brain circulation and metabolism in hemodialysis patients. J.Am. Soc. Nephrol. 1999, 10:854-863.
24. Muller M., van der Graaf Y., Visseren F.L., Mali W.P., Geerlings M.I. Hypertension and longitudinal changes in cerebral blood flow: the SMART-MR study. Ann. Neurol. 2012, 71:825-833.
25. Sarnak M.J., Tighiouart H., Manjunath G., MacLeod B., Griffith J., Salem D., Levey A.S. Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study. J.Am. Coll. Cardiol. 2002, 40:27-33.
26. Simons P.C., Algra A., van de Laak M.F., Grobbee D.E., van der Graaf Y. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur. J. Epidemiol. 1999, 15:773-781.
27. Sojkova J., Najjar S.S., Beason-Held L.L., Metter E.J., Davatzikos C., Kraut M.A., Zonderman A.B., Resnick S.M. Intima-media thickness and regional cerebral blood flow in older adults. Stroke 2010, 41:273-279.
28. Spivak J.L. Polycythemia vera: myths, mechanisms, and management. Blood 2002, 100:4272-4290.
29. Vorstrup S., Lass P., Waldemar G., Brandi L., Schmidt J.F., Johnsen A., Paulson O.B. Increased cerebral blood flow in anemic patients on long-term hemodialytic treatment. J.Cereb. Blood Flow Metab. 1992, 12:745-749.
30. Wade J.P. Transport of oxygen to the brain in patients with elevated haematocrit values before and after venesection. Brain 1983, 106:513-523.
31. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Vitamin and Mineral Nutrition Information System 2011, World Health Organization, World Health Organization, Geneva, (WHO/NMH/NHD/MNM/11.1), Available at:, Accessed January 20, 2014. http://www.who.int/vmnis/indicators/haemoglobin.pdf.
32. Zakai N.A., Katz R., Hirsch C., Shlipak M.G., Chaves P.H., Newman A.B., Cushman M. Aprospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch. Intern. Med. 2005, 165:2214-2220.